Qualification for Cone-Optogenetics

Status Recruiting

Clinical Trial Summary

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Clinical Trial Description

In a subset of patients with inherited retinal dystrophies (IRDs), cones lose their light-sensitive outer segments but remain alive in a dormant stage. This creates an opportunity to resensitize them through targeted optogenetic tools. However, the true proportion of low vision patients harboring dormant, non-functional cones, is currently unknown. The worldwide multicenter retrospective study (EyeConic) aims to estimate the proportion of low vision patients with remaining cone cell bodies for the first time. ;

Study Design

Related Conditions & MeSH terms

Retinal Dystrophies

Clinical Trial Details

NCT number	NCT05218928
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact	Lucas Janeschitz-Kriegl, MD
Phone	+41787494373
Email	lucas.janeschitz@iob.ch
Status	Recruiting
Phase
Start date	July 1, 2021
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04123626` - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	Phase 1/Phase 2
Completed	`NCT01546181` - Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
Recruiting	`NCT03592017` - Performance of Long-wavelength Autofluorescence Imaging	N/A
Recruiting	`NCT03853252` - iPS Cells of Patients for Models of Retinal Dystrophies	N/A
Recruiting	`NCT04855045` - An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.	Phase 2/Phase 3
Recruiting	`NCT06177977` - SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)	N/A
Completed	`NCT02983305` - Optical Head-Mounted Display Technology for Low Vision Rehabilitation	N/A
Not yet recruiting	`NCT06455826` - MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)	Phase 1
Recruiting	`NCT05573984` - Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Completed	`NCT03763227` - Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy	Phase 2
Completed	`NCT04945772` - Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]	Phase 2
Recruiting	`NCT05294978` - EyeConic: Qualification for Cone-Optogenetics
Completed	`NCT03843840` - Dual Wavelength OCT
Enrolling by invitation	`NCT06162585` - Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
Recruiting	`NCT02014389` - Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer
Not yet recruiting	`NCT06319872` - The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration	Phase 1